CLYM
Climb Bio
CLYM
CLYM
23 hedge funds and large institutions have $44M invested in Climb Bio in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
6% less capital invested
Capital invested by funds: $46.8M → $44M (-$2.85M)
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
Holders
23
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$934K | |
| 2 | +$92.8K | |
| 3 | +$6.9K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$5.02K |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$2.86K |
Top Sellers
| 1 | -$981K | |
| 2 | -$40K | |
| 3 | -$17.4K | |
| 4 |
CPIG
Chicago Partners Investment Group
Chicago,
Illinois
|
-$9.64K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.26K |